Cereals Canada provides updates on the Prairie crop

May 30, 2025

Cereals Canada has launched its Growing Season Progress Report.

Cereals Canada works with provincial departments of agriculture in Alberta, Saskatchewan, and Manitoba throughout the growing season to gather information on seeding, crop conditions and quality, and harvest progress for spring wheat.

The information is compiled and presented in an interactive, user-friendly format with maps, provincial highlights, and links to crop reports. Historical data for the past five years is also available for comparison purposes.

Global buyers use the interactive report to stay informed, according to Leif Carlson, Cereals Canada director of market intelligence and trade policy.

“With most wheat acres located in the Prairies, the report provides global buyers with a glimpse into how the Canadian wheat crop is progressing, from seeding to harvest,” Carlson said. “Global customers want to be kept informed about how the Canadian wheat crop is progressing over the growing season. We make it easy for them to quickly get all their information in one place.”

The report includes information about Western Canadian wheat, including environmental factors that could impact crop quality or development.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.